Novartis Sets Sandoz Spinoff Date For October 4
Portfolio Pulse from Benzinga Newsdesk
Novartis has announced the spinoff date for its generics division, Sandoz, as October 4. The decision will be finalized in an Extraordinary General Meeting (EGM) of Novartis shareholders.
August 18, 2023 | 11:51 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Novartis has set the spinoff date for Sandoz, which could potentially impact the company's stock price.
The spinoff of Sandoz could potentially impact Novartis' stock price as it may change the company's revenue structure and market perception. However, the exact impact is uncertain until the spinoff is finalized and the market reacts to it.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100